{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T17:29:27Z","timestamp":1725730167075},"publisher-location":"Totowa, NJ","reference-count":26,"publisher":"Humana Press","isbn-type":[{"type":"print","value":"9781617371431"},{"type":"electronic","value":"9781592598175"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004]]},"DOI":"10.1007\/978-1-59259-817-5_1","type":"book-chapter","created":{"date-parts":[[2013,6,8]],"date-time":"2013-06-08T00:19:45Z","timestamp":1370650785000},"page":"1-11","source":"Crossref","is-referenced-by-count":3,"title":["Diagnosis of Multiple Myeloma"],"prefix":"10.1007","author":[{"given":"Robert A.","family":"Kyle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel E.","family":"Bergsagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4065\/78.1.21","volume":"78","author":"RA Kyle","year":"2003","unstructured":"Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 2003; 78:21\u201333.","journal-title":"Mayo Clin Proc"},{"key":"1_CR2","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1001\/archinte.1981.00340100071017","volume":"141","author":"AL Suchman","year":"1981","unstructured":"Suchman AL, Coleman M, Mouradian JA, Wolf DJ, Saletan S. Aggressive plasma cell myeloma: a terminal phase. Arch Intern Med 1981; 141:1315\u20131320.","journal-title":"Arch Intern Med"},{"key":"1_CR3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3109\/10428199809057562","volume":"30","author":"J Blade","year":"1998","unstructured":"Blade J, Kyle RA. Multiple myeloma in young patients: clinical presentation and treatment approach. Leuk Lymphoma 1998; 30:493\u2013501.","journal-title":"Leuk Lymphoma"},{"key":"1_CR4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0272-6386(12)80314-3","volume":"20","author":"RL Heilman","year":"1992","unstructured":"Heilman RL, Velosa JA, Holley KE, Offord KP, Kyle RA. Long-term follow-up and response to chemotherapy in patients with light-chain deposition disease. Am J Kidney Dis 1992; 20:34\u201341.","journal-title":"Am J Kidney Dis"},{"key":"1_CR5","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1002\/1097-0142(19921001)70:7<1899::AID-CNCR2820700716>3.0.CO;2-3","volume":"70","author":"D Leifer","year":"1992","unstructured":"Leifer D, Grabowski T, Simonian N, Demirjian ZN. Leptomeningeal myelomatosis presenting with mental status changes and other neurologic findings. Cancer 1992; 70:1899\u20131904.","journal-title":"Cancer"},{"key":"1_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.7326\/0003-4819-96-1-47","volume":"96","author":"DG Savage","year":"1982","unstructured":"Savage DG, Lindenbaum J, Garrett TJ. Biphasic pattern of bacterial infection in multiple myeloma. Ann Intern Med 1982; 96:47\u201350.","journal-title":"Ann Intern Med"},{"key":"1_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1034\/j.1600-065X.2003.00056.x","volume":"194","author":"RA Kyle","year":"2003","unstructured":"Kyle RA, Rajkumar SV. Monoclonal gammopathies of undetermined significance: a review. Immunol Rev 2003; 194:112\u2013139.","journal-title":"Immunol Rev"},{"key":"1_CR8","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/(SICI)1096-8652(199712)56:4<288::AID-AJH16>3.0.CO;2-5","volume":"56","author":"MQ Lacy","year":"1997","unstructured":"Lacy MQ, Gertz MA, Hanson CA, Inwards DJ, Kyle RA. Multiple myeloma associated with diffuse osteosclerotic bone lesions: a clinical entity distinct from osteosclerotic myeloma (POEMS syndrome). Am J Hematol 1997; 56:288\u2013293.","journal-title":"Am J Hematol"},{"key":"1_CR9","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1001\/archinte.1985.00360080125019","volume":"145","author":"RA Kyle","year":"1985","unstructured":"Kyle RA, Schreiman JS, McLeod RA, Beabout JW. Computed tomography in diagnosis and management of multiple myeloma and its variants. Arch Intern Med 1985; 145:1451\u20131452.","journal-title":"Arch Intern Med"},{"key":"1_CR10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1046\/j.1365-2141.1997.4213236.x","volume":"99","author":"S Kusumoto","year":"1997","unstructured":"Kusumoto S, Jinnai I, Itoh K, et al. Magnetic resonance imaging patterns in patients with multiple myeloma. Br J Haematol 1997; 99:649\u2013655.","journal-title":"Br J Haematol"},{"key":"1_CR11","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1182\/blood.V90.6.2127","volume":"90","author":"LA Moulopoulos","year":"1997","unstructured":"Moulopoulos LA, Dimopoulos MA. Magnetic resonance imaging of the bone marrow in hematologic malignancies. Blood 1997; 90:2127\u20132147.","journal-title":"Blood"},{"key":"1_CR12","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1182\/blood.V91.7.2501","volume":"91","author":"PR Greipp","year":"1998","unstructured":"Greipp PR, Leong T, Bennett JM, et al. Plasmablastic morphology\u2014an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory Group. Blood 1998; 91:2501\u20132507.","journal-title":"Blood"},{"key":"1_CR13","first-page":"89","volume-title":"Myeloma: Biology and Management","author":"R Bartl","year":"1998","unstructured":"Bartl R, Frisch B. Bone marrow biopsy and aspiration for diagnosis of multiple myeloma. In: Melpas JS, Bergsagel DE, Kyle RA, Anderson KC, eds. Myeloma: Biology and Management, 2nd ed. Oxford, England: Oxford University Press, 1998:89\u2013121.","edition":"2"},{"issue":"17","key":"1_CR14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/sonc.2002.34069","volume":"29","author":"RA Kyle","year":"2002","unstructured":"Kyle RA. Diagnosis of multiple myeloma. Semin Oncol 2002; 29 (suppl 17):2\u20134.","journal-title":"Semin Oncol"},{"key":"1_CR15","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","volume":"121","author":"International Myeloma Working Group","year":"2003","unstructured":"International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003; 121:749\u2013757 .","journal-title":"Br J Haematol"},{"key":"1_CR16","first-page":"47","volume":"10","author":"RA Kyle","year":"2002","unstructured":"Kyle RA. Diagnosis and treatment of multiple myeloma in the elderly. Clin Geriatr 2002; 10:47\u201356.","journal-title":"Clin Geriatr"},{"key":"1_CR17","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1056\/NEJMoa01133202","volume":"346","author":"RA Kyle","year":"2002","unstructured":"Kyle RA, Themeau TM, Rajkumar SV, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 2002; 346:564\u2013569.","journal-title":"N Engl J Med"},{"key":"1_CR18","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1056\/NEJM198006123022405","volume":"302","author":"RA Kyle","year":"1980","unstructured":"Kyle RA, Greipp PR. Smoldering multiple myeloma. N Engl J Med 1980; 302:1347\u20131349.","journal-title":"N Engl J Med"},{"key":"1_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0025-6196(12)60015-9","volume":"68","author":"RA Kyle","year":"1993","unstructured":"Kyle RA. \u201cBenign\u201d monoclonal gammopathy\u2014after 20 to 35 years of follow-up. Mayo Clin Proc 1993; 68:26\u201336.","journal-title":"Mayo Clin Proc"},{"key":"1_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1365-2141.1992.tb08245.x","volume":"81","author":"J Blade","year":"1992","unstructured":"Blade J, Lopez-Guillermo A, Rozman C, et al. Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance. Br J Haematol 1992; 81:391\u2013394.","journal-title":"Br J Haematol"},{"key":"1_CR21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/000456329102800310","volume":"28","author":"PG Riches","year":"1991","unstructured":"Riches PG, Sheldon J, Smith AM, Hobbs JR. Overestimation of monoclonal immunoglobulin by immunochemical methods. Ann Clin Biochem 1991; 28:253\u2013259.","journal-title":"Ann Clin Biochem"},{"key":"1_CR22","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S0025-6196(12)65066-6","volume":"62","author":"PR Greipp","year":"1987","unstructured":"Greipp PR, Witzig TE, Gonchoroff NJ, et al. Immunofluorescence labeling indices in myeloma and related monoclonal gammopathies. Mayo Clin Proc 1987; 62:969\u2013977.","journal-title":"Mayo Clin Proc"},{"key":"1_CR23","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1200\/JCO.1988.6.6.1041","volume":"6","author":"TE Witzig","year":"1988","unstructured":"Witzig TE, Gonchoroff NJ, Katzmann JA, Themeau TM, Kyle RA, Greipp PR. Peripheral blood B cell labeling indices are a measure of disease activity in patients with monoclonal gammopathies. J Clin Oncol 1988; 6:1041\u20131046.","journal-title":"J Clin Oncol"},{"key":"1_CR24","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1182\/blood.V88.5.1780.1780","volume":"88","author":"TE Witzig","year":"1996","unstructured":"Witzig TE, Gertz MA, Lust JA, Kyle RA, O\u2019Fallon WM, Greipp PR. Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma. Blood 1996; 88:1780\u20131787.","journal-title":"Blood"},{"key":"1_CR25","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/sj.bmt.1701767","volume":"23","author":"K Kiel","year":"1999","unstructured":"Kiel K, Cremer FW, Rottenburger C, et al. Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplantation. Bone Marrow Transplantation 1999; 23:1019\u20131027.","journal-title":"Bone Marrow Transplantation"},{"key":"1_CR26","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1080\/028418600750063479","volume":"39","author":"T Rasmussen","year":"2000","unstructured":"Rasmussen T, Jensen L, Johnsen HE. The clonal hierarchy in multiple myeloma. Acta Oncologica 2000; 39:7:765\u2013770.","journal-title":"Acta Oncologica"}],"container-title":["Biology and Management of Multiple Myeloma"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-59259-817-5_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T20:55:34Z","timestamp":1595883334000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-59259-817-5_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004]]},"ISBN":["9781617371431","9781592598175"],"references-count":26,"URL":"https:\/\/doi.org\/10.1007\/978-1-59259-817-5_1","relation":{},"subject":[],"published":{"date-parts":[[2004]]}}}